Orion Biotech Opportunities Corp. Units
ORIAU
ORIAU was delisted on the 25th of April, 2023.
18 hedge funds and large institutions have $56.2M invested in Orion Biotech Opportunities Corp. Units in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less funds holding
Funds holding: 21 → 18 (-3)
24% less capital invested
Capital invested by funds: $73.8M → $56.2M (-$17.6M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$5.97K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$5.96M |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$5.18M |
| 3 |
KC
Kepos Capital
New York
|
-$4.96M |
| 4 |
Millennium Management
New York
|
-$2.49M |
| 5 |
SC
Sculptor Capital
New York
|
-$1.24M |
ORIAU Hedge Fund Activity: Q4 2021 in Review
18 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q4 2021, worth a combined $56.2M — down 24% from $73.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ORIAU and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $5.97K. The largest seller was Periscope Capital, exiting entirely with an estimated $5.96M sold.
- 18 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q4 2021, down from 21 in Q3 2021.
- Funds reported $56.2M of Orion Biotech Opportunities Corp. Units stock for Q4 2021, down 24% quarter-over-quarter.
- 3 funds opened new Orion Biotech Opportunities Corp. Units positions in Q4 2021 and 6 closed out, a net change of -3 holders.
- The largest Orion Biotech Opportunities Corp. Units buyer in Q4 2021 was Jane Street, an estimated $5.97K added.
- The largest Orion Biotech Opportunities Corp. Units seller in Q4 2021 was Periscope Capital, an estimated $5.96M sold.
Based on aggregated 13F filings for Q4 2021.